TipRanks
Axsome Therapeutics Inc (DE:19X)
XETRA:19X

Compare Axsome Therapeutics (19X) vs. Competitors

5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Axsome Therapeutics
€179.10
€8.15B
-46.13
55.71%
15 Buy
1 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$30.57
$3.40B
8.73
-8.77%
11 Buy
4 Hold
0 Sell
Moderate Buy
Jazz Pharmaceuticals
$260.23
$15.02B
15.21
68.36%
18 Buy
1 Hold
0 Sell
Strong Buy
Neurocrine
$153.37
$14.79B
20.35
4.72%
23 Buy
3 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$38.95
$2.29B
12.57
45.43%
4 Buy
4 Hold
1 Sell
Moderate Buy
Biohaven Ltd.
$14.38
$1.82B
-2.56
-20.91%
7 Buy
3 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:19X
Axsome Therapeutics
157.50
56.55
56.02%
ACAD
ACADIA Pharmaceuticals
19.65
-1.66
-7.79%
JAZZ
Jazz Pharmaceuticals
231.19
93.41
67.80%
NBIX
Neurocrine
143.47
4.39
3.16%
HRMY
Harmony Biosciences Holdings
39.34
12.78
48.12%
BHVN
Biohaven Ltd.
11.88
-3.46
-22.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts